President Donald Trump has signed an executive order aimed at aggressively lowering the cost of in vitro fertilization (IVF), positioning the move as a response to rising concerns over family formation and fertility treatment accessibility.
The decision comes as part of his broader election campaign strategy, reinforcing his appeal among middle-class families struggling with high medical expenses.
The order is expected to trigger resistance from conservative factions within his base, particularly those who oppose IVF on ethical and religious grounds.
Trump has given his advisers 90 days to formulate policies that would reduce out-of-pocket costs associated with IVF, which can range from $12,000 to $30,000 per cycle in the US.
The initiative underscores his administration’s effort to expand access to fertility treatments while simultaneously maintaining a staunch anti-abortion stance—a contradiction that has left both supporters and critics questioning his long-term policy direction.
His decision follows the Alabama Supreme Court’s controversial ruling that frozen embryos could be considered children, sparking fears that IVF access could be threatened under Republican leadership.
Fertility treatment costs in the US
The high cost of IVF in the US remains one of the biggest barriers for couples seeking fertility treatment.
A single IVF cycle can cost between $12,000 and $25,000, with additional expenses for medication, genetic testing, and embryo storage pushing the total price even higher.
Unlike other developed nations that offer government-subsidized fertility treatments, the US relies on private insurance coverage, which remains inconsistent across states and employers.
Trump’s order is expected to push for policy changes that could either mandate broader insurance coverage or introduce federal subsidies for IVF.
During his campaign, he promised to make fertility treatment more affordable, a pledge that his administration is now attempting to fulfill.
His push for lower IVF costs comes as fertility rates in the US continue to decline, with birth rates reaching a record low in 2023.
Addressing this issue has become a political talking point, with both Democrats and Republicans recognizing the economic implications of a shrinking workforce and aging population.
Critics argue that while Trump is now championing affordable IVF, his administration played a role in restricting reproductive healthcare access through the appointment of Supreme Court justices who overturned Roe v. Wade.
The conservative push against abortion rights has inadvertently placed fertility treatments under scrutiny, with some anti-abortion advocates voicing concerns over embryo destruction during IVF procedures.
Political divisions over reproductive rights
Trump’s executive order has sparked a deep divide within the Republican Party, exposing internal conflicts over reproductive rights.
While many conservatives have long supported pro-family policies, the ethical implications of IVF have made the issue contentious.
Anti-abortion groups argue that the procedure often results in unused embryos, which they equate to the loss of human life.
This ideological stance has led to resistance against legislation that would ensure IVF access, as seen in last year’s Senate vote where almost all Republican senators opposed a measure to protect fertility treatments.
The Alabama ruling further intensified the debate, forcing Trump to clarify his stance on the issue.
In response to the growing backlash, he declared himself “totally in favor of IVF” and positioned himself as a leader in expanding access to fertility treatments.
His decision reflects an attempt to balance the demands of pro-family conservatives with the religious right, which remains a key voting bloc.
Meanwhile, Democrats, led by Vice President Kamala Harris, have leveraged the issue to highlight contradictions within Trump’s reproductive health policies.
Harris has repeatedly emphasized that attacks on abortion rights could spill over into fertility treatments, warning that Republican-led states may impose restrictions that make IVF less accessible.
With reproductive rights expected to be a central theme in the upcoming election, Trump’s executive order appears to be a strategic move to mitigate potential political damage.
The future of IVF access in the US
The long-term impact of Trump’s IVF policy remains uncertain, with many questioning whether his administration will follow through on reducing costs or if the order is primarily a political gesture.
The move comes at a time when the IVF industry is facing increased scrutiny, particularly after the Alabama Supreme Court ruling raised concerns about the legal status of frozen embryos.
Clinics in the state briefly paused IVF treatments in response to legal uncertainties, highlighting the fragile nature of fertility treatment access under shifting political landscapes.
The commercialization of fertility treatments remains a major concern. With the US IVF market valued at over $8 billion, industry players may resist regulatory changes that could affect profitability.
Trump’s executive order has not yet outlined specific mechanisms to reduce costs, raising doubts about whether meaningful financial relief will reach families in need.
As the 2024 election nears, both parties are expected to amplify their positions on IVF, with Republicans seeking to reconcile internal divisions and Democrats pushing for broader reproductive healthcare protections.
Trump’s move to champion IVF affordability may win support from middle-class families, but it also risks alienating the religious conservatives who have long been a crucial part of his voter base.
The coming months will determine whether his administration can successfully navigate this politically sensitive issue or whether the contradictions in his reproductive health policies will become a liability.
The post Trump’s IVF executive order: Costs, political impact, and conservative backlash appeared first on Invezz
